[Coronary artery bypass after Kawasaki disease]

Vera Santos1, Ana Sofia Simões, Ana Teixeira

  • 1Serviço de Pediatria, Hospital de Faro, EPE, Faro, Portugal. verasantosm@yahoo.com

Insights

Kawasaki disease (KD) can lead to serious heart complications later in life, even after initial normal evaluations. Early diagnosis and consistent cardiac monitoring are crucial for managing this pediatric vasculitis.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Systemic Vasculitis

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children, potentially causing coronary artery aneurysms and ischemic heart disease.
  • Early diagnosis and treatment with immunoglobulin and aspirin are standard for KD.
  • Long-term sequelae may manifest years after initial presentation.

Observation:

  • A teenage boy diagnosed with KD at age seven had normal acute-phase echocardiograms.
  • At age eleven, he presented with chest pain and exertional dyspnea.
  • Exercise nuclear perfusion scans indicated hypoperfusion in the left anterior descending and right coronary artery territories.

Findings:

  • Cardiac catheterization revealed proximal occlusions in both the left anterior descending and right coronary arteries.
  • The patient underwent successful coronary artery bypass graft surgery, including internal mammary artery to LAD and saphenous vein graft to RC.
  • Surgical intervention resulted in a favorable clinical outcome.

Implications:

  • This case underscores the critical need for vigilant, long-term cardiological follow-up in children with a history of Kawasaki disease.
  • Delayed complications of KD, such as coronary artery occlusion, can occur despite initial normal cardiac assessments.
  • Prompt recognition and management of late-onset cardiac issues are vital for preventing severe ischemic heart disease in pediatric patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...